ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 287 filers reported holding ALKERMES PLC in Q2 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,342 | -44.5% | 155 | -38.0% | 0.00% | – |
| Q2 2023 | $7,825 | -72.2% | 250 | -75.0% | 0.00% | – |
| Q1 2023 | $28,190 | +7.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $26,130 | +18.8% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | -26.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $30,000 | +15.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | +116.7% | 1,000 | +100.0% | 0.00% | – |
| Q4 2021 | $12,000 | +200.0% | 500 | +151.3% | 0.00% | – |
| Q4 2019 | $4,000 | -98.4% | 199 | -98.5% | 0.00% | -100.0% |
| Q3 2019 | $252,000 | +25100.0% | 12,931 | +18112.7% | 0.01% | – |
| Q2 2019 | $1,000 | -98.7% | 71 | -96.0% | 0.00% | -100.0% |
| Q3 2018 | $75,000 | +31.6% | 1,767 | +28.2% | 0.00% | +33.3% |
| Q2 2018 | $57,000 | -9.5% | 1,378 | +24.8% | 0.00% | -25.0% |
| Q1 2018 | $63,000 | – | 1,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |